Results 221 to 227 of about 61,360 (227)

Microglia depletion leads to increased susceptibility to ocular hypertension-dependent glaucoma

Cory A. Diemler, Michael MacLean, Sarah E. Heuer, Amanda A. Hewes, Olivia J. Marola, Richard T. Libby, Gareth R. Howell   +6 more
openalex   +1 more source

Management and toxicological analysis of ocular hypertension after EyeCee^® ONE intraocular lens implantation: a case series. [PDF]

BMC Ophthalmol
Bastelica P, Magny R, Poupon J, Sonigo B, Aubert T, Brignole-Baudouin F, Buffault J, Baudouin C, Labbé A.   +8 more
europepmc   +1 more source

Outcomes of a non-diffractive extended depth of focus intraocular lens in patients with well-controlled glaucoma and ocular hypertension. [PDF]

Int J Ophthalmol
Liu JR, Szigiato AA, Harasymowycz P.
europepmc   +1 more source

Co-delivery of ripasudil and dexamethasone in trabecular meshwork cells for potential prevention of GC-induced ocular hypertension

Tilahun Ayane Debele, Yong Yuan, Winston W.‐Y. Kao, Chia‐Yang Liu, Eskezeia Y Dessie, Yoonjee C. Park   +5 more
openalex   +1 more source

Responsiveness to Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension.

JAMA Ophthalmol
Yang Y, Xu K, Chen Z, Zhang Y, Ye Q, Ping YT, Fan Y, Liu P, Nathwani N, Jiang Y, Gazzard G, Yu M, LiGHT China Trial Study Group.   +12 more
europepmc   +1 more source

Quality of Life and Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study.

JAMA Ophthalmol
Gordon MO, Gao F, Burkland J, Huecker JB, Gardiner SK, Ramulu P, Zangwill LM, Heuer DK, Higginbotham EJ, Parrish RK, Kass MA.   +10 more
europepmc   +1 more source